VEGFA and neoplasm: In fact, many evidences show that aflibercept binds to VEGF-A with higher affinity and a faster association rate than bevacizumab, and that it has the additional property to bind VEGF-B and PlGF which have been largely implicated in promoting tumor growth and spread (19, 20).